Menu
Telegram chat:
@cpa_house
Got questions?
Telegram chat
@cpa_house

Offers

Filters

Tier
Payouts currency

Offers found 8381

Temporarily stopped.

Viarex (BG)
Viarex (BG)
Male libido enhancement product.
ID: 6572
Not active
Create flow
CR 0.11%
Approval Rate
Category Male enhancers
Country Temporarily stopped.

Temporarily stopped.

Pro Drops (XK)
Pro Drops (XK)
Prostate gland health product.
ID: 6571
Not active
Create flow
CR
Approval Rate
Category Prostatitis
Country Temporarily stopped.

Temporarily stopped.

Viarex (CZ)
Viarex (CZ)
Male libido enhancement product.
ID: 6570
Not active
Create flow
CR 1.63%
Approval Rate 40.89%
Category Male enhancers
Country Temporarily stopped.

Temporarily stopped.

Motion Mat (DE, AT)
Motion Mat (DE, AT)
Weight regulation product.
ID: 6569
Not active
Create flow
CR
Approval Rate
Category Physical products
Country Temporarily stopped.

Temporarily stopped.

Invanil (ID)
Invanil (ID)
Joints health product.
ID: 6568
Not active
Create flow
CR 0.12%
Approval Rate 14.29%
Category Joints
Country Temporarily stopped.

Temporarily stopped.

Hondro Start (TR)
Hondro Start (TR)
Joints health product.
ID: 6567
Not active
Create flow
CR 44.62%
Approval Rate 51.72%
Category Joints
Country Temporarily stopped.

Temporarily stopped.

Omnihack Low Price (CO)
Omnihack Low Price (CO)
Organs of vision health product.
ID: 6566
Not active
Create flow
CR 20.83%
Approval Rate 40%
Category Vision
Country Temporarily stopped.

Temporarily stopped.

Elesse Cream (ES)
Elesse Cream (ES)
Skin rejuvenation product.
ID: 6565
Not active
Create flow
CR
Approval Rate
Category Rejuvenation
Country Temporarily stopped.

Temporarily stopped.

Opticor (GR)
Opticor (GR)
Product for managing high blood pressure.
ID: 6564
Not active
Create flow
CR 0.29%
Approval Rate 100%
Category Hypertension
Country Temporarily stopped.

Temporarily stopped.

Ultravix Joints (MX)
Ultravix Joints (MX)
Joints health product.
ID: 6563
Not active
Create flow
CR 7.17%
Approval Rate 28.52%
Category Joints
Country Temporarily stopped.